AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28363687 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment strategy with angiographic guidance (n=450)
Number of subjects: 899
Study 28363687 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment strategy with angiographic guidance (n=449)
Number of subjects: 899
Study 28363687 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment strategy
Number of subjects: 899
Study 28363687 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment strategy
Number of subjects: 899
Study 26131189 — intervention group
Group type: EXPERIMENTAL
Intervention: LJCT (Lower Joint Cavity Treatment)
Number of subjects: 56
Study 26131189 — intervention group
Group type: COMPARATOR
Intervention: UJCT (Upper Joint Cavity Treatment)
Number of subjects: 56
Study 23434107 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (CFNB)
Number of subjects: 66
Study 23434107 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural analgesia (CEA)
Number of subjects: 66
Study 22104275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4900
Study 22104275 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO definition of metabolic syndrome
Number of subjects: 4900
Study 22104275 — intervention group
Group type: EXPERIMENTAL
Intervention: ATPIII definition of metabolic syndrome
Number of subjects: 4900
Study 22104275 — intervention group
Group type: EXPERIMENTAL
Intervention: IDF definition of metabolic syndrome
Number of subjects: 4900
Study 19834012 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO) 40,000 IU intravenously
Number of subjects: 522
Study 19834012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study 19834012 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO)
Number of subjects: 522
Study 16467019 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg daily for at least 60 days
Number of subjects: 76
Study 16467019 — intervention group
Group type: COMPARATOR
Intervention: Control group (only emollients for topical therapy)
Number of subjects: 76
Study 12789169 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0
Study 11288031 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (50 mU/kg/h) for 4 hours
Number of subjects: 16
Study 11288031 — intervention group
Group type: COMPARATOR
Intervention: Insulin infusion
Number of subjects: 16
Study 9107633 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Product (DP) measured above the blood lactate threshold (LT)
Number of subjects: 90
Study 9107633 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) measured above the blood lactate threshold (LT)
Number of subjects: 90
Study 9107633 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) measured above the blood lactate threshold (LT)
Number of subjects: 90
Study 9107633 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant work rate exercise sessions at various submaximal intensities
Number of subjects: 90
Study 9107633 — intervention group
Group type: EXPERIMENTAL
Intervention: DP break point (DPBP) determining protocol
Number of subjects: 90
Study 8461565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) administered continuously
Number of subjects: 50
Study 8461565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) administered cyclically
Number of subjects: 50
Study 8461565 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) administered cyclically (50-60 mg/day)
Number of subjects: 50
Study 3488178 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealing during lymph node dissections (n = 26)
Number of subjects: 35
Study 3488178 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealing for treatment of manifest lymph fistulae (n = 9)
Number of subjects: 35
Study 29505477 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent cap-assisted endoscopic sclerotherapy
Number of subjects: 120
Study 27524190 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+ MPA sequential therapy
Number of subjects: 140
Study 27524190 — intervention group
Group type: EXPERIMENTAL
Intervention: E2V+ MPA sequential therapy
Number of subjects: 140
Study 27524190 — intervention group
Group type: EXPERIMENTAL
Intervention: E2V+ P sequential therapy
Number of subjects: 140
Study 27524190 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuntai capsule
Number of subjects: 140
Study 27524190 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohosh extract
Number of subjects: 140
Study 24467258 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-accepting passenger
Number of subjects: 66
Study 24467258 — intervention group
Group type: COMPARATOR
Intervention: Risk-averse passenger
Number of subjects: 66
Study 22244909 — intervention group
Group type: EXPERIMENTAL
Intervention: Class I radical hysterectomy
Number of subjects: 125
Study 22244909 — intervention group
Group type: COMPARATOR
Intervention: Class III radical hysterectomy
Number of subjects: 125
Study 20705220 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed changes in low-density lipoprotein cholesterol management guidelines
Number of subjects: 0
Study 20705220 — intervention group
Group type: COMPARATOR
Intervention: Current management guidelines for low-density lipoprotein cholesterol
Number of subjects: 0
Study 18580019 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-lock therapy using vancomycin and gentamycin
Number of subjects: 69
Study 18580019 — intervention group
Group type: COMPARATOR
Intervention: Routine TCC management
Number of subjects: 69
Study 16197624 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan 200 mg/m2 on day 1, levo-leucovorin (LV) 250 mg/m2, and 5-fluorouracil (5-FU) 850 mg/m2 via intravenous bolus on day 2
Number of subjects: 254
Study 16197624 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan/5-FU/LV regimen
Number of subjects: 254
Study 12017209 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg once daily
Number of subjects: 501
Study 12017209 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily
Number of subjects: 501
Study 12017209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 11757258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative-creative program of assertive behavior and self-concept, implemented through group play-sessions once a week during the academic year
Number of subjects: 154
Study 8674567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavitary silver nitrate (AgNO3) stick insertion
Number of subjects: 50
Study 8674567 — intervention group
Group type: COMPARATOR
Intervention: Conventional excision technique
Number of subjects: 50
Study 2335304 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session educational intervention on DSM-IIIR affective and anxiety disorders
Number of subjects: 0
Study 2335304 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 879070 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing cystine at 6 mg/100 ml
Number of subjects: 0
Study 879070 — intervention group
Group type: COMPARATOR
Intervention: Formula containing cystine at 28 mg/100 ml
Number of subjects: 0
Study 879070 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of tyrosine less than 50 mg/kg of body weight
Number of subjects: 0
Study 879070 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary approach to reduce elevated plasma tyrosine levels
Number of subjects: 0
Study 31418805 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth Subsalicylate (BSS)
Number of subjects: 439
Study 31418805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 27813208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias training programme
Number of subjects: 2
Study 26011508 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality-targeted intervention program (Adventure trial) delivered by trained teachers
Number of subjects: 1038
Study 26011508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensation-seeking intervention
Number of subjects: 1038
Study 23542637 — intervention group
Group type: EXPERIMENTAL
Intervention: valacyclovir 1000 mg twice daily
Number of subjects: 34
Study 23542637 — intervention group
Group type: COMPARATOR
Intervention: acyclovir 400 mg twice daily
Number of subjects: 34
Study 21884720 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisoprodol 700 mg
Number of subjects: 15
Study 21884720 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisoprodol 350 mg
Number of subjects: 15
Study 21884720 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg carisoprodol)
Number of subjects: 15
Study 17944966 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable polylactide-polyglycolide acid sponge (Fisiograft)
Number of subjects: 20
Study 17944966 — intervention group
Group type: COMPARATOR
Intervention: Natural healing by clot formation
Number of subjects: 20
Study 16857993 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 290
Study 16857993 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 290
Study 16857993 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical patients
Number of subjects: 290
Study 16857993 — intervention group
Group type: COMPARATOR
Intervention: Medical patients
Number of subjects: 290
Study 14659122 — intervention group
Group type: EXPERIMENTAL
Intervention: USC/Van Nuys Prognostic Index
Number of subjects: 1036
Study 14659122 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy or breast conservation with or without radiation therapy
Number of subjects: 1036
Study 10864708 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural measures of pain assessment
Number of subjects: 0
Study 10864708 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rating pain scores
Number of subjects: 0
Study 9176844 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium diet (200 mmol/day)
Number of subjects: 12
Study 9176844 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-restricted diet (20 mmol/day)
Number of subjects: 12
Study 1412641 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg/kg body weight)
Number of subjects: 53
Study 1412641 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg body weight) + Desipramine (1.3-2.8 mg/kg body weight) daily for 3 days
Number of subjects: 53
Study 3874641 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1.5 mg kg‐1
Number of subjects: 71
Study 3874641 — intervention group
Group type: COMPARATOR
Intervention: Etomidate 0.2 mg kg‐1
Number of subjects: 71
Study 3874641 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone 1.5 mg kg‐1
Number of subjects: 71
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 80 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 90 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 100 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 110 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 120 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 130 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 140 CPM
Number of subjects: 40
Study 30338845 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression frequency of 150 CPM
Number of subjects: 40
Study 28502186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VP)
Number of subjects: 95
Study 28502186 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with VP, indomethacin, and treatment of bacterial vaginosis (BV)
Number of subjects: 95
Study 28502186 — intervention group
Group type: COMPARATOR
Intervention: Dydrogesterone, 17-OH progesterone (17OHP), and micronized oral progesterone (OP)
Number of subjects: 95
Study 26242382 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐54452840 20 mg
Number of subjects: 32
Study 26242382 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐54452840 80 mg
Number of subjects: 32
Study 26242382 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐54452840 240 mg
Number of subjects: 32
Study 26242382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 26242382 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 32
Study 24518260 — intervention group
Group type: EXPERIMENTAL
Intervention: MEG-fMRI data correlation analysis during cognitive tasks
Number of subjects: 0
Study 24518260 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency correlation analysis
Number of subjects: 0
Study 22686076 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinganbao Capsule (8 capsules, three times a day)
Number of subjects: 60
Study 22686076 — intervention group
Group type: COMPARATOR
Intervention: Heluo Shugan Tablet (5 pills, thrice daily)
Number of subjects: 60
Study 20105114 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 0
Study 20105114 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study 16580386 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin, 20 mg daily plus oral contraceptive pill (OCP)
Number of subjects: 48
Study 16580386 — intervention group
Group type: COMPARATOR
Intervention: OCP alone
Number of subjects: 48
Study 14749148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg
Number of subjects: 100
Study 14749148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.6 mg
Number of subjects: 100
Study 14749148 — intervention group
Group type: COMPARATOR
Intervention: Ramosetron 0.15 mg
Number of subjects: 100
Study 14749148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 14749148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg vs Ramosetron 0.6 mg
Number of subjects: 100
Study 14749148 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study 10997687 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hyperglycemia
Number of subjects: 0
Study 10997687 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of glucose-induced pathways
Number of subjects: 0
Study 10997687 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased reactive oxygen species (ROS) production
Number of subjects: 0
Study 9066400 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 324
Study 9066400 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 324
Study 9066400 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 324
Study 8299674 — intervention group
Group type: COMPARATOR
Intervention: Sauna (3 x 10 min; temperature 80-100 degrees C; relative humidity 30-50%)
Number of subjects: 6
Study 8299674 — intervention group
Group type: COMPARATOR
Intervention: Post-sauna period
Number of subjects: 6
Study 2945527 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg/day
Number of subjects: 10
Study 2945527 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 240 mg/day
Number of subjects: 10
Study 2945527 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 360 mg/day
Number of subjects: 10
Study 31143922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear worn for 12 hours daily
Number of subjects: 20
Study 31143922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear worn during the day (8 am‐8 pm)
Number of subjects: 20
Study 31143922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear worn during the night (8 pm‐8 am)
Number of subjects: 20
Study 31143922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear compliance during summer months
Number of subjects: 20
Study 29540069 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide inhalation (carboxyhemoglobin 22%)
Number of subjects: 12
Study 29540069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 26847398 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (PVI) irrigation
Number of subjects: 3027
Study 26847398 — intervention group
Group type: COMPARATOR
Intervention: No Betadine irrigation (Control)
Number of subjects: 3027
Study 25191663 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 33
Study 25191663 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 33
Study 25191663 — intervention group
Group type: COMPARATOR
Intervention: Midazolam and Propofol
Number of subjects: 33
Study 25191663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operational stress
Number of subjects: 33
Study 23471324 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspherical intraocular lens
Number of subjects: 52
Study 23471324 — intervention group
Group type: COMPARATOR
Intervention: Spherical intraocular lens
Number of subjects: 52
Study 23471324 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow tinted intraocular lens
Number of subjects: 52
Study 23471324 — intervention group
Group type: COMPARATOR
Intervention: Acrylic ultraviolet filter IOL
Number of subjects: 52
Study 22885319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3mg)
Number of subjects: 130
Study 22885319 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (4mg)
Number of subjects: 130
Study 18246730 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR for detection of E.histolytica DNA in liver abscess aspirate
Number of subjects: 30
Study 18246730 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigen detection by ELISA in liver abscess aspirate
Number of subjects: 30
Study 16915076 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (TG)
Number of subjects: 106
Study 16915076 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 106
Study 12675644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified management with diet, exercise, and insulin
Number of subjects: 55
Study 10872954 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous non-surgical therapy (one or more non-surgical procedures performed during 3 successive years)
Number of subjects: 1021
Study 10872954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent non-surgical therapy
Number of subjects: 1021
Study 9171121 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) + laparoscopic cholecystectomy (LC)
Number of subjects: 60
Study 9171121 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (ES) alone
Number of subjects: 60
Study 9171121 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 60
Study 7901256 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 161
Study 7901256 — intervention group
Group type: COMPARATOR
Intervention: Ibopamine
Number of subjects: 161
Study 7901256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 7901256 — intervention group
Group type: COMPARATOR
Intervention: Digoxin and Ibopamine
Number of subjects: 161
Study 3004797 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotope washout technique
Number of subjects: 48
Study 30522484 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive patient follow-up intervention
Number of subjects: 1900
Study 27689478 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth All Engaged! (text message intervention)
Number of subjects: 852
Study 27689478 — intervention group
Group type: COMPARATOR
Intervention: Teen Outreach Program (control)
Number of subjects: 852
Study 25014615 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 120
Study 21420841 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat diet (>40% calories from fat)
Number of subjects: 29
Study 21420841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet (approximately 20% calories from fat)
Number of subjects: 29
Study 21420841 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat meal
Number of subjects: 29
Study 21420841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat meal
Number of subjects: 29
Study 19439362 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioner-based minimal intervention for workers with stress-related sick leave (MISS)
Number of subjects: 0
Study 19439362 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 18703552 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-gauge system
Number of subjects: 60
Study 18703552 — intervention group
Group type: COMPARATOR
Intervention: 20-gauge system
Number of subjects: 60
Study 15722300 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-112 (0.25% eye drops, 4 times a day for 8 weeks)
Number of subjects: 34
Study 15722300 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 times a day for 8 weeks)
Number of subjects: 34
Study 12698515 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system (TNS)
Number of subjects: 112
Study 12698515 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 112
Study 10376453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation plus sclerotherapy
Number of subjects: 103
Study 10376453 — intervention group
Group type: COMPARATOR
Intervention: Ligation alone
Number of subjects: 103
Study 8872083 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory handbook (MHB)
Number of subjects: 40
Study 8872083 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 40
Study 1844692 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment effects across centers
Number of subjects: 0
Study 1844692 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper confidence limits for delta
Number of subjects: 0
Study 1844692 — intervention group
Group type: EXPERIMENTAL
Intervention: Tests based on upper confidence limits
Number of subjects: 0
Study 1844692 — intervention group
Group type: EXPERIMENTAL
Intervention: Example from a four‐center clinical trial
Number of subjects: 0